U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 4,732 records

Showing results for "secondary".

  1. Summary of the Design Plan for the National Evaluation of the CHIPRA Quality Demonstration Grant Program (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/design_plan_for_chipra.pdf
    July 01, 2012 - include administrative and claims data; original survey data from physicians; and, for some questions, secondary

  2. Facilitator Guide: Build Your SSI Prevention Bundle (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/cusp/learn-from-defects-facguide.docx
    January 01, 2017 - Identify any new information and secondary defects introduced by the intervention.

  3. Co-producing a Diagnosis

    www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/resources/diagnostic-toolkit/08-diagnostic-cap-provider-training-slides.pptx
    August 01, 2021 - Eliciting the patient’s agenda - secondary analysis of recorded clinical encounters.

  4. Team Structure and Assembly (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/perinatal-care-2/hemorrhage_2-team-structure-speaker-notes.pdf
    July 01, 2023 - • Direct patient care may be a secondary function with the exception of small facilities.

  5. CDSiC Stakeholder Center Progress Report (pdf file)

    digital.ahrq.gov/sites/default/files/CDSiC%20Stakeholder%20Center%20Quarterly%20Report%20Q2%202024_7.18.24.pdf
    September 01, 2024 - Secondary outcome measures include proxy measures that impact value such as clinician and patient satisfaction

  6. "Do You Want Everything Done?": Clarifying Code Status | PSNet

    psnet.ahrq.gov/web-mm/do-you-want-everything-done-clarifying-code-status
    March 27, 2024 - The Case A 63-year-old woman with a history of liver transplantation secondary to hepatitis C, low back

  7. Failure to Ensure Patient Safety Leads to Patient Falls in Nursing Homes. | PSNet

    psnet.ahrq.gov/web-mm/failure-ensure-patient-safety-leads-patient-falls-nursing-homes
    August 14, 2024 - Medications were given to assist with agitation secondary to dementia and a psychiatric evaluation was

  8. Gout Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
    March 01, 2016 - studies of which 45 were included in our analysis (7 RCTs, 1abstract that has not been published, 5 secondary … SRs 6 new trials 3 observational studies in 6 articles 5 SRs 7 new trials and 1 abstract 5 secondary … identified 11 SRs10,49-58 and one meta- analysis.59 In addition, we identified one new abstract60 and five secondary

  9. Evidence Summary: Speech and Language Delay and Disorders in Children: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening
    January 23, 2024 - or language delay and disorders that are not caused by an injury or another condition (acquired or “secondary … ” disorders) such as hearing loss (eg, secondary to infection or genetic syndrome) or autism. … Secondary prevention of paediatric language disability: a comparison of parents and nurses as screening

  10. Archived: Final Evidence Summary: Falls Prevention in Older Adults: Counseling and Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
    December 15, 2010 - they were designed to assess fall prevention based on assessment of falling or falls as a primary or secondary … The Winchester falls project: a randomised controlled trial of secondary prevention of falls in older … Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism

  11. Kidney-Stone-Prevention Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
    March 01, 2013 - In an attempt to distinguish the effect of secondary prevention from lithotripsy, we excluded studies … Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis … A randomized trial of low- animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis

  12. Microsoft Word - 2009-01.doc (pdf file)

    hcup-us.ahrq.gov/reports/methods/2009_01.pdf
    January 01, 2009 - Elements for Exclusions: Three data elements required for certain QIs were not available in every State: “secondary … data elements are used to exclude specific cases from the QI measures: • The PSIs and PDIs that use secondary … deliveries with no exclusions Patient Safety Indicators PSI 1 Complications of anesthesia in any secondary

  13. Kidney-Stones-Draft-Appendi-C (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
    January 01, 2024 - past 10 years; at least 50% of the stone composition was calcium oxalate or calcium phosphate or both Secondary … A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis … previous 5 years with at least one calculus within the previous 2 years, hyperuricosuria, normocalciuria Secondary … Persons 18 years or older with history of hyperoxaluria secondary to a known underlying enteric disorder … A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis

  14. Supp-Analysisicd10Readmissions (xls file)

    hcup-us.ahrq.gov/db/nation/nrd/Supp-AnalysisICD10Readmissions.xlsx
    January 01, 2017 - NEOPL DIAG W/O CC/MCC * 1,163 * * * * * * * * * * * * * * 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 6,997 69.52 3.45 Stable 1,760 19.59 2,071 20.58 5.07 Stable 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 43,310 71.44 0.44 Stable 29,548 46.89 28,732 47.40 1.08 Stable 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAG W/O CC/MCC 1,163 975 -16.16 * * * * * * * * * * * * * 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 71.44 40,709 71.55 0.15 * 28,732 47.40 25,961 45.63 -3.72 * 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY

  15. Microsoft Word - Deliverable #94.10 - Final 2001 NIS Comparison Report 10-2. (pdf file)

    hcup-us.ahrq.gov/reports/methods/NIS_Comparison_Report_2001.pdf
    January 01, 2001 - If a symptom appears as a first-listed code and a diagnosis appears as a secondary code, the diagnosis … If a symptom appeared as a first- listed code and a diagnosis was listed as a secondary code, the diagnosis … comparing NIS records to MedPAR, only the NIS discharges for which Medicare was the expected primary or secondary … For example, when a symptom appeared as the first-listed code, it was reassigned as a secondary diagnosis … primary or HCUP 2001 NIS (10/22/2004) 20 Deliverable #94.10: Revised NIS Comparison Report, 2001 secondary

  16. MEDLINE Searches (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
    March 01, 2009 - • Trials report breast cancer results as primary or secondary outcomes.‡ • Trials enroll women … • No breast cancer results as primary or secondary outcomes. • Laboratory or animal studies. … >3 months >100 participants Primary or secondary breast cancer outcomes; other benefits … • A secondary outcome is a major outcome of a study that the study was designed and powered to demonstrate … Tested in secondary population? Population adequately described?

  17. 2001 HCUP Nationwide Inpatient Sample (NIS) Comparison Report

    hcup-us.ahrq.gov/db/nation/nis/reports/2001niscomparisonrpt.jsp
    November 01, 2015 - If a symptom appears as a first-listed code and a diagnosis appears as a secondary code, the diagnosis … If a symptom appeared as a first-listed code and a diagnosis was listed as a secondary code, the diagnosis … comparing NIS records to MedPAR, only the NIS discharges for which Medicare was the expected primary or secondary … For example, when a symptom appeared as the first-listed code, it was reassigned as a secondary diagnosis … both fee-for-service and managed care) for which Medicare was the expected payer (either primary or secondary

  18. Nrd 2014 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core.PDF
    January 01, 2014 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 788 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 5,724 0.04% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 40,008 … 0.27% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 2,351 0.02% 849: RADIOTHERAPY … 0.12% 40: Multiple myeloma 8,232 0.06% 41: Cancer; other and unspecified primary 3,146 0.02% 42: Secondary … disease) 30,493 0.20% 98: Essential hypertension 24,605 0.17% 99: Hypertension with complications and secondary

  19. 2016-07 (pdf file)

    hcup-us.ahrq.gov/reports/methods/2016-07.pdf
    January 01, 2016 - Leukemias 1,325 70.6 40: Multiple myeloma 210 72.4 41: Cancer; other and unspecified primary 85 71.8 42: Secondary … transmitted disease) 1,881 72.0 98: Essential hypertension 263 61.2 99: Hypertension with complications and secondary … Leukemias 314 77.7 40: Multiple myeloma 41 73.2 41: Cancer; other and unspecified primary 35 74.3 42: Secondary … disease) 702 70.1 98: Essential hypertension 2,023 58.1 99: Hypertension with complications and secondary … Use of Secondary Procedure Days in the AHRQ Quality Indicators, Version 3.1 Table 5.

  20. Nis 2013 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Core.PDF
    January 01, 2013 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 381 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 2,285 0.03% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 19,601 … 0.28% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 1,353 0.02% 849: RADIOTHERAPY … 0.11% 40: Multiple myeloma 3,608 0.05% 41: Cancer; other and unspecified primary 1,446 0.02% 42: Secondary … disease) 13,838 0.19% 98: Essential hypertension 11,052 0.16% 99: Hypertension with complications and secondary
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (1196)

hcup-us.ahrq.gov (1163)

effectivehealthcare.ahrq.gov (808)

www.ahrq.gov (695)

digital.ahrq.gov (428)

www.uspreventiveservicestaskforce.org (380)

cds.ahrq.gov (21)

cdsic.ahrq.gov (16)

integrationacademy.ahrq.gov (8)

meps.ahrq.gov (7)

datatools.ahrq.gov (4)

qualityindicators.ahrq.gov (4)

pso.ahrq.gov (2)